IL33 and cancer: Finally, in a recent report, suppression of breast cancer progression and metastasis was observed in a murine breast cancer model wherein mice lacked the IL-33 signaling receptor, ST2[86], further supporting the role of the IL-33/ST2 axis in tumor formation and the progression of cancer.